Browsing: but the FDA said it would continue to review information and communicate with the public if data emerges suggesting booster doses are needed for this pediatric population.
The agency announced in a news release that they also would shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 Vaccine and a booster dose to at least five months.